NASDAQ:BMRA
Biomerica Inc.
Biomerica Inc.'s revenue fell 16.2% in fiscal 2026 to $4.5M while operating margin fell to −119.5%. The diluted share count rose 26.9%.Summary generated from Biomerica Inc.'s SEC filings. Latest annual report filed Aug 31, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$4.5M
Revenue growth−16.2%
Revenue, 5-yr CAGR−9.2%
Gross margin8.1%
Operating margin−119.5%
Net margin−84.8%
ROICn/a
Return on equity−112.1%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+26.9%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 19 | 5 | 5 | 5 | 4 |
| Operating income | −5 | −7 | −6 | −5 | −5 |
| Net income | −5 | −7 | −6 | −5 | −4 |
| Free cash flow | −1 | −6 | −5 | n/a | n/a |
Recent filings
- 10-K/AAmended annual report for the fiscal year ended May 31, 2026
Sep 28, 2026 - 10-KAnnual report for the fiscal year ended May 31, 2026
Aug 31, 2026 - 4Insider transaction report
Aug 27, 2026 - 4Insider transaction report
Aug 27, 2026 - 8-KEntry into a material agreement
Aug 26, 2026 - 8-KEntry into a material agreement
Jun 4, 2026 - 10-QQuarterly report for the period ended Feb 28, 2026
Apr 13, 2026 - 10-QQuarterly report for the period ended Nov 30, 2025
Jan 14, 2026